Jiajian Xiefei Tang alleviates asthma airway inflammation by regulating the STAT3/IL-17 signaling pathway through its effective component licochalcone A.
- DOI
- 10.4196/kjpp.25.384
- Published
- 2026 Jul 21
- Container
- The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4196/kjpp.25.384,
title = {Jiajian Xiefei Tang alleviates asthma airway inflammation by regulating the STAT3/IL-17 signaling pathway through its effective component licochalcone A.},
author = {Lv Y and Wu S and Liu X},
year = {2026},
journal = {The Korean journal of physiology \& pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology},
doi = {10.4196/kjpp.25.384},
url = {https://doi.org/10.4196/kjpp.25.384}
}RIS
TY - JOUR TI - Jiajian Xiefei Tang alleviates asthma airway inflammation by regulating the STAT3/IL-17 signaling pathway through its effective component licochalcone A. AU - Lv Y AU - Wu S AU - Liu X PY - 2026 JO - The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology DO - 10.4196/kjpp.25.384 UR - https://doi.org/10.4196/kjpp.25.384 ER -
APA
Y, L., S, W., & X, L. (2026). Jiajian Xiefei Tang alleviates asthma airway inflammation by regulating the STAT3/IL-17 signaling pathway through its effective component licochalcone A.. The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology. https://doi.org/10.4196/kjpp.25.384
Source records
- pubmed · retrieved 2026-09-26T20:45:02.269Z